Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Thomas A. Shea currently holds 31,489 shares of EPIRUS Biopharmaceuticals, Inc. (EPRS), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Thomas A. Shea has been a net neutral trader of EPRS stock. They have purchased $0 and sold $0 worth of shares.
Thomas A. Shea's most recent insider trade was on Feb 27, 2016, when they sold 1,554 shares at $2.80 per share.
Thomas A. Shea serves as Executive at EPIRUS Biopharmaceuticals, Inc. (EPRS). They have executed 4 insider transactions totaling $0 over their tenure at the company.
Thomas A. Shea holds the position of Executive at EPIRUS Biopharmaceuticals, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 11 years and currently hold a stake valued at $0.
Thomas A. Shea has shown a balanced trading pattern, with $0 in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a balanced approach to trading.
The largest transaction by Thomas A. Shea was on Nov 3, 2015, when they sold $37.6K worth of EPRS shares. This transaction involved 28,926 shares at $1.30 per share.
Thomas A. Shea currently owns 31,489 shares of EPIRUS Biopharmaceuticals, Inc. (EPRS), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Thomas A. Shea's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Thomas A. Shea has 4 Form 4 filings on record as an insider at EPIRUS Biopharmaceuticals, Inc..
Set alerts for Thomas A. Shea and 40,000+ other insiders.